// App-Quantinova.ai

15460 2014 AHA : Pulmonary Hypertension is Associated with Apoptosis, the Downregulation of S100A1, the Upregulation of S100A6 and the Receptor for Advanced Glycation end-Products

Researchers

Presenter

  • Vassilios Salpeas

Principal Investigators

  • Nikos Kavatzas

  • Shehla Izhar

  • Jean-Francois Desjardins

  • Krystyna Teichert-Kuliszewska

  • Ioannis K Rizos

  • Thomas G Parker

Medical Centers

  • National and Kapodistrian University of Athens, Athens, Greece

  • St. Michael's Hosp, Toronto, ON, Canada

  • Attikon University Hospital, Athens, Greece.

Locations

  • Canada

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Advanced Glycosylation End-Product Specific Receptor

  • B-cell lymphoma 2

  • BCL2 associated X, apoptosis regulator

  • Prostatic acid phosphatase

  • S100 Calcium Binding Protein A6

  • S100 calcium-binding protein B

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved